[1] Dweck MR, Joshi S, Murigu T, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271–1279.
[2] Gulati A, Jabbour A, Ismail TF, et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 2013;309:896–908.
[3] Wong TC, Piehler K, Meier CG, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012;126:1206–1216.
[4] Wong TC, Piehler KM, Kang IA, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J 2014;35:657–664.
[5] Vassiliou VS, Perperoglou A, Raphael CE, et al. Midwall fibrosis and 5-year outcome in patients with moderate and severe aortic stenosis. J Am Coll Cardiol 2017;69:1755–1756.
[6] Radenkovic D, Weingärtner S, Ricketts L, Moon JC, Captur G. T1 mapping in cardiac MRI. Heart Fail Rev. 2017;22(4):415-430. doi:10.1007/s10741-017-9627-2
[7] Kellman P, Hansen MS. T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson 2014;16:2-12.
[8] Weingärtner S, Meßner NM, Zöllner FG, Akçakaya M, Schad LR. Black-blood native T1mapping: Blood signal suppression for reduced partial voluming in the myocardium. Magn Reson Med 2017;78:484–493.
[9] Ferreira VM, Wijesurendra RS, Liu A, Greiser A, Casadei B, Robson MD, Neubauer S, Piechnik SK. Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias. J Cardiovasc Magn Reson 2015;17:77–85.
[10] Meßner NM, Budjan J, Loßnitzer D, Papavassiliu T, Schad LR, Weingärtner S, Zöllner FG. Saturation-recovery myocardial t1-mapping during systole: accurate and robust quantifcation in the presence of arrhythmia. Sci Rep 2018;8:5251–5260.
[11] Zhao L, Li S, Ma X, Greiser A, et al. Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation. J Cardiovasc Magn Reson 2016;18:13–23.
[12] Captur G, Bhandari A, Brühl R, et al. T1 mapping performance and measurement repeatability: results from the multi-national T1 mapping standardization phantom program (T1MES). J Cardiovasc Magn Reson 2020;22:31–41.
[13] Wang Y, Vidan E, Bergman GW. Cardiac motion of coronary arteries: variability in the rest period and implications for coronary MR angiography. Radiology 1999;213:751–758.
[14] Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardised cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson 2013;15:91–110.
[15] Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003;17:323–329.
[16] Doesch C, Lossnitzer D, Rudic B, et al. Right ventricular and right atrial involvement can predict atrial fibrillation in patients with hypertrophic cardiomyopathy? Int J Med Sci 2016;13:1–7.
[17] Zareian M, Ciuffo L, Habibi M, et al. Left atrial structure and functional quantitation using cardiovascular magnetic resonance and multimodality tissue tracking: validation and reproducibility assessment. J Cardiovasc Magn Reson 2015;17:52–56.
[18] Captur G, Lopes LR, Patel V, et al. Abnormal cardiac formation in hypertrophic cardiomyopathy: fractal analysis of trabeculae and preclinical gene expression. Circ Cardiovasc Genet 2014;7:241–248.
[19] Weingärtner S, Akçakaya M, Basha T, et al. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med 2014;71:1024–1034.
[20] Roujol S, Weingärtner S, Foppa M, et al. Accuracy, precision, and reproducibility of four T1 mapping sequences: a head-to-head comparison of MOLLI, ShMOLLI, SASHA, and SAPPHIRE. Radiology 2014;272:683–689.
[21] von Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer MA, et al. Myocardial T1 and T2 mapping at 3T: reference values, influencing factors and implications. J Cardiovasc Magn Reson 2013;15:53–60.
[22] Dong Y, Yang D, Han Y, et al. Age and gender impact the measurement of myocardial interstitial fibrosis in a healthy adult chinese population: a cardiac magnetic resonance study. Front Physiol 2018;9:140–150.
[23] Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT, Bluemke DA. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson 2012;14:27–35.
[24] Reiter U, Reiter G, Dorr K, Greiser A, Maderthaner R, Fuchsjäger M. Normal diastolic and systolic myocardial T1 values at 1.5-T MR imaging: correlations and blood normalization. Radiology 2014;271:365–372.
[25] Oken DE, Boucek RJ. Quantitation of collagen in human myocardium. Circ Res 1957;5:357–361.
[26] Kawel-Boehm N, Dellas Buser T, Greiser A, Bieri O, Bremerich J, Santini F. In-vivo assessment of normal T1 values of the right-ventricular myocardium by cardiac MRI. Int J Cardiovasc Imaging 2014;30:323–328.
[27] Secchi F, Alì M, Monti CB, Greiser A, Pluchinotta FR, Carminati M, Sardanelli F. Right and left ventricle native T1 mapping in systolic phase in patients with congenital heart disease. Acta Radiol 2021;62:334–340.
[28] Karur GR, Robison S, Iwanochko RM, et al. Use of myocardial t1 mapping at 3.0 t to differentiate anderson-fabry disease from hypertrophic cardiomyopathy. Radiology 2018;288:398–406.
[29] Wang J, Zhao H, Wang Y, Herrmann HC, Witschey WRT, Han Y. Native T1 and T2 mapping by cardiovascular magnetic resonance imaging in pressure overloaded left and right heart diseases. J Thoracic Dis 2018;10:2968-2975.
[30] Mehta BB, Auger DA, Gonzalez JA, et al. Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance. J Cardiovasc Mag Res 2015;17:110–120.
[31] Chin CW, Semple S, Malley T, et al. Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis. Eur Heart J Cardiovasc Imaging 2014;15:556–565.
[32] Puntmann VO, Voigt T, Chen Z, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging 2013;6:475–84.
[33] Vassiliou V, Heng EL, Sharma P, et al. Reproducibility of T1 mapping 11-heart beat MOLLI Sequence. J Cardiovasc Magn Reson 2015;17:W26.
[34] Weingärtner S, Meßner NM, Budjan J, et al. Myocardial T1-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI. J Cardiovasc Magn Reson 2017;18:84–90.